Home › Core › ISCC-IDs › 28C4aguB3LWxo

View ISCC-ID

Core Data

28C4aguB3LWxo
ISCC-ID - digital asset identifier
CCFiFUxJjFXdQ-CTP7jkjRdn7ou-CDGE9C79JyLn3-CRfCUjbv8ejCX
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

damage to lipids proteins dna and rna in mild cognitive impairment

Ledger Reference

coblo
Source Ledger/Blockchain
12406429
N-th ISCC Decleration on source ledger
26b2f09c288c0711d9cd13085b39b8e57db9321e3fd686cfb21b7be6c669342f
Hash of block that includes the ISCC-DECLARATION
35d635fdecf017edfb5c2f7864e883fc0b13e72f6dd768a29ad96f3860de3199
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Damage to Lipids, Proteins, DNA, and RNA in Mild Cognitive Impairment", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "William R. Markesbery", "@type": "Person"}, {"name": "Mark A. Lovell", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://jamanetwork.com/journals/jamaneurology/articlepdf/794121/nnr60016_954_956.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "American Medical Association (AMA)", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1001/archneur.64.7.954", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCFiFUxJjFXdQ-CTP7jkjRdn7ou-CDGE9C79JyLn3-CRfCUjbv8ejCX", "propertyID": "ISCC"}], "datePublished": "2007-07-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close